According to a recent study by Future Market Insights (FMI), the global microfluidics market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 5.9 Bn in 2021 to over US$ 17.8 Bn by 2031. This reflects a cumulative CAGR of around 11.1% over the forecast period (2022-2031).
The flow of liquids through various microscopic channels or mediums such as nozzles, pumps or chips is based on a technology known as microfluidics. The products based on such technology can control and direct the fluids at the lowest dimensions which could range from ten to hundreds of micrometers.
Request a report sample to gain comprehensive insights at
Microfluidics helps facilitate many assays concurrently. Thus, increasing the throughput where a good level of spatiotemporal control is possible. This reduces the consumption and cost of precious fluids, chemical and biological assays. Numerous applications utilizes microfluidics based technology such as clinical diagnostics, analytical testing, point-of-care testing and drug delivery. Genomics, proteomics and cell-based analysis uses microfluidics technology-based instruments and chips during analytical testing.
|Data Points||Market Insights|
|Market Value 2021||USD 5.9 Bn|
|Market Value 2022||USD 6.8 Bn|
|Market Value 2031||USD 17.8 Bn|
|Share of Top 5 Countries||46.3%|
|Key Players||The key players in Microfluidics Market are Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad Laboratories, Inc. , Qiagen NV, SCHOTT AG, thinXXS Microtechnology|
Microfluidics systems provides features such as ease of automation, reduction in the overall consumption of sample and reagents while reducing the analysis time. Thus, it can be considered as an attractive solution for various assays like chemical and biological assay. The system also allows to conduct assays parallel, thus decreasing the cost of the assays and time.
Microfluidics in 3D cell culture has recently enabled the development of microenvironments that facilitate differentiation of tissues and can also replicate the interface between 2 tissues. It can further facilitate spatiotemporal chemical gradients, as well as mechanical micro – environment of living organs.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-398
There is an ever-increasing demand for microfluidic lab-on-chip technology in the biomedical, pharmaceutical industries as well in anti-terrorism, environmental, food and military applications. To further add to this, the development of consumers, environmental and security markets, the speed, portability, availability and low costs of miniaturized biosensors have huge commercial potential.
Strategic collaborations among key players drive the microfluidics market to develop novel microfluidic platforms for drug discovery, portable diagnostic devices and others. The collaboration space is dominated by the players who have a strong product portfolio and patented technologies dedicated to clinical research and in-vitro diagnostics applications along with the local GMP certified manufacturing facilities.
In order to overcome difficulties associated with the fabrication included into the microfluidics devices, many companies are substituting the mixers in these devices with the bubbles at large. This can be the opportunity to improve the efficiency of the microfluidics devices creating a huge opportunity in the market.
Key Takeaways from Microfluidics Study
- The ceramics segment is anticipated to hold the maximum share of 39.9% in 2022, expanding at 13.0% CAGR during the forecast period. Ceramics’ superior chemical resistivity, flexibility, and strength make them ideal for producing microfluidics devices, as seen by their significant market share.
- The point of care testing segment is projected to account for 32.6% of the total market share in 2022 by application. In the fields of genomics and proteomics, point-of-care testing devices offer a lot of potential. These devices, for example, aid in the identification of the DNA of bacteria that cause various diseases and are also employed in protein analysis.
- In-vitro diagnostics and life science research together hold over 53% of the market in 2022 and this trend is expected to continue during the forecast period as well. The growing number of experiment carried out in life science research using microfluidics is rising. This is propelling the sector forward. Aside from that, with increasing diseases, is increasing the in-vitro diagnostics demand.
- North America is expected to account for about 25.4% of the global microfluidics market. The high frequency and growth in incidence of various diseases, and government funding for the research and clinical testing by various institutions in the North America will assist market expansion.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-398
Who is winning?
The key market players covered by FMI include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad Laboratories, Inc., Qiagen NV, SCHOTT AG and thinXXS Microtechnology.
Some of the leading manufacturers of the microfluidics market are focusing on the development of advanced and cost-effective products and undertaking acquisitions to increase global presence.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Micro-Hospitals Market – Micro-hospitals are small scale In-patient facility that offers a variety of emergency medical services. They mostly focused on treating low-acuity patients and provides ambulatory and emergency services.
Micro-CT Scanners Market – Micro-CT Scanners Market is get to be an ambitious in coming forecast, as from the history Micro-CT scanners has great evaluation process. Micro-CT (Micro-Computed Tomography) Scanners is also known as X-ray imaging in 3 D.
Microplate Washer Market – Microplate washers are used to remove reagents from sample wells such that they can be prepared for the next process. The microplate washer dispenses wash solution into the sample wells.
Antimicrobial Peptides Market – Antimicrobial Peptides are molecules that form part of host defense mechanism in prokaryotic as well as eukaryotic cells capable of protecting against the harmful infective threats modelled by the bacteria, viruses and even fungi.
Real Time Continuous Microbiological Monitoring Systems Market – Pharmaceutical and biotechnology companies who produce medicine and biotech products are concern about airborne microbial contamination. Traditionally, these companies use active air samplers or settling plate method to detect the airborne microbial contamination.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org